Shouichi Ihara

Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Biomarkers of Immune-Checkpoint Inhibitor for Non-Small Cell Lung Cancer

Seigo Minami, Shouichi Ihara, Shouko Ikuta et al. · World Journal of Oncology · 2019 · 66 citations · Full text

Life Sciences, Immunology, Oncology +17

Sarcopenia and Visceral Adiposity Did Not Affect Efficacy of Immune-Checkpoint Inhibitor Monotherapy for Pretreated Patients With Advanced Non-Small Cell Lung Cancer

Seigo Minami, Shouichi Ihara, Tsunehiro Tanaka et al. · World Journal of Oncology · 2020 · 53 citations · Full text

Medicine, Oncology, Pharmacology +17

Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer

Seigo Minami, Yoshitaka Ogata, Shouichi Ihara et al. · Lung Cancer Targets and Therapy · 2017 · 40 citations · Full text

Medicine, Oncology, Chemotherapy +15

Pretreatment Lung Immune Prognostic Index Is a Prognostic Marker of Chemotherapy and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

Seigo Minami, Shouichi Ihara, Kiyoshi Komuta · World Journal of Oncology · 2019 · 40 citations · Full text

Medicine, Oncology, Pharmacology +17

Low Body Mass Index Is an Independent Prognostic Factor in Patients With Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

Seigo Minami, Shouichi Ihara, Kanako Nishimatsu et al. · World Journal of Oncology · 2019 · 37 citations · Full text

Medicine, Oncology, Molecular Oncology +16